Clinical evaluation of irAEs in ptients with ICI
Not Applicable
- Conditions
- immune related adverse events
- Registration Number
- JPRN-UMIN000037931
- Lead Sponsor
- Toho University School of Medicine
- Brief Summary
Compared to the non-diabetes, diabetes has not been associated with irAEs risks for baseline characteristics and after propensity score matching analysis. During a mean follow-up of 30 months, overall (OS) and cancer specific progression free survival (PFS) were significantly improved in irAEs group. After propensity scores analyses, DM was significantly associated with increased risks of lower OS.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 88
Inclusion Criteria
Not provided
Exclusion Criteria
nothing
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method